Veracyte
VCYT
25.13
+0.09
+0.36%
Veracyte
US · VCYT
#2330 by market cap
Listed 1970
25.13
+0.09
+0.36%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 7 analysts
Buy
Avg price target 48.00 +91.0%
Price target rangecurrent 25.13
Low30.00
Avg48.00
High69.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-11 | Stephens | -- | Buy | 40.00 |
| 2026-11-10 | Piper Sandler | -- | Buy | 30.00 |
| 2026-11-09 | UBS | -- | Buy | 35.00 |
| 2026-11-05 | Piper Sandler | -- | Buy | 54.00 |
| 2026-09-17 | Piper Sandler | -- | Buy | 54.00 |
| 2026-09-15 | William Blair | -- | Buy | -- |
| 2026-09-15 | Craig-Hallum | -- | Buy | -- |
| 2026-09-15 | Freedom Capital Markets | -- | Buy | 66.00 |
| 2026-09-15 | Needham | -- | Buy | 69.00 |
| 2026-09-09 | UBS | -- | Buy | 65.00 |
| 2026-08-24 | Piper Sandler | -- | Buy | 54.00 |
| 2026-08-04 | Piper Sandler | -- | Buy | 54.00 |
| 2026-08-04 | Morgan Stanley | -- | Sell | 44.00 |
| 2026-08-04 | Stephens | -- | Buy | 55.00 |
| 2026-08-03 | CCORF | -- | Hold | 50.00 |
| 2026-07-31 | William Blair | -- | Buy | -- |
| 2026-07-31 | Piper Sandler | -- | Buy | 66.00 |
| 2026-07-31 | Needham | -- | Buy | 69.00 |
| 2026-07-31 | Guggenheim | -- | Buy | 65.00 |
| 2026-07-15 | Piper Sandler | -- | Buy | 66.00 |
| 2026-07-13 | CCORF | -- | Hold | 60.00 |
| 2026-07-09 | Morgan Stanley | -- | Sell | 47.00 |
| 2026-07-08 | Jefferies | -- | Buy | 70.00 |
| 2026-06-29 | Guggenheim | -- | Buy | 65.00 |
| 2026-06-01 | Needham | -- | Buy | 57.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-04 | After close | ±15.68% | -54.30% (beat) |
| 2026/Q2 | 2026-07-30 | After close | ±13.99% | -22.52% (beat) |
| 2026/Q1 | 2026-05-05 | After close | ±20.93% | +24.93% (beat) |
| 2025/Q4 | 2026-02-25 | After close | ±19.81% | +8.48% (in line) |
| 2025/Q3 | 2025-11-04 | After close | ±12.74% | +27.46% (beat) |
| 2025/Q2 | 2025-08-06 | After close | ±10.66% | +15.48% (beat) |
| 2025/Q1 | 2025-05-07 | After close | ±18.77% | +1.20% (in line) |
| 2024/Q4 | 2025-02-24 | After close | ±21.31% | -14.99% (in line) |
| 2024/Q3 | 2024-11-06 | After close | ±13.60% | +2.05% (in line) |
| 2024/Q2 | 2024-08-06 | After close | ±14.21% | +23.97% (beat) |
| 2024/Q1 | 2024-05-07 | After close | -- | -4.33% |
| 2023/Q4 | 2024-02-22 | After close | ±20.77% | -8.87% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Veracyte discussion 0 comments